elective lung cancer surgery in the covid-19 era: how do we do it. ¬© Fondazione IRCCS Istituto Nazionale dei Tumori 2020.The coronavirus 2019 (COVID-19) pandemic has caused significant mortality around the world and the focus has been on reducing the number of infections. In order not to compromise treatment of oncology patients, reducing the number of patients with COVID-19 undergoing treatment is mandatory. We reviewed the experience of the National Institute of Cancer in Milan and compared it with our experience.